A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphoma

Oncologist

Volumn 18, Issue 11, 2013, Pages 1189-

  Bosly, André ^a   Grigg, Andrew ^b   Holte, Harald ^c   Gisselbrecht, Christian ^d   Radford, John ^e   Rossi, Andrea ^f   Lopez Guillermo, Armando ^g   Trneny, Marek ^h   Sebban, Catherine ⁱ   Hagberg, Hans ^j   da Costa, Fernando Leal ^k   Colombat, Philippe ^l   Bron, Dominique ^m   Coiffier, Bertrand ⁿ  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^b AUSTIN HOSPITAL   (Australia)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d SAINT LOUIS HOSPITAL   (France)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f Azienda Ospedaliera Papa Giovanni XXIII   (Italy)

^g HOSPITAL CLÍNIC   (Spain)

^h NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

ⁱ CENTRE LÉON BÉRARD   (France)

^j UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^k Institute of Saude   (Portugal)

^l CHU BRETONNEAU   (France)

^m JULES BORDET INSTITUTE   (Belgium)

ⁿ CENTRE HOSPITALIER LYON SUD   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON;

ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; DISEASE COURSE; EVENT FREE SURVIVAL; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEM CELL TRANSPLANTATION; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CONSOLIDATION CHEMOTHERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTERFERON-ALPHA; LYMPHOMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RECURRENCE; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 84887420090     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2013-0223     Document Type: Article

References (0)